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Relations among plasma epinephrine, norepinephrine 
and renin activity and systolic pressure, diastolic pres-
sure, heart rate and the product of heart rate and systolic 
pressure (rate-pressure product) were evaluated in 31 
healthy men whose arterial pressure spanned the range 
from normal to mildly elevated. Measurements were made 
during 60 minutes with the patient in the supine position 
and during lO minutes of quiet standing. In the supine 
position, highly significant regressions were found be-
tween systolic pressure or rate-pressure product and 
plasma epinephrine, but not between these variables and 
norepinephrine or renin activity. A weakly significant 
correlation was also found between heart rate and nor-
epinephrine. On standing, norepinephrine and epineph-
The determinants of systolic and diastolic arterial pressures 
in the early phases of the hypertensive process remain to 
be characterized. This problem is compounded by difficulty 
in establishing an exact classification such that' 'normoten-
sive" and "hypertensive" groups can be easily distin-
guished for comparison (1,2). Epidemiologic studies (3) 
have avoided such an arbitrary division and tend to rely on 
regression relations between arterial pressure as a continuous 
variable and subsequent rates of appearance of cardiovas-
cular disease (3). On this basis, we evaluated a group of 
healthy, well characterized men with a range of arterial 
pressures varying between normal and that which is con-
sidered to be mildly hypertensive. Plasma norepinephrine, 
epinephrine concentration and renin activity were measured, 
and correlations examined with respect to systolic pressure, 
diastolic pressure, heart rate and heart rate X systolic pres-
sure (rate-pressure product). 
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rine increased significantly. In this position, rate-pres-
sure product was significantly related by regression anal-
ysis only with plasma epinephrine. Weakly significant 
correlations between systolic pressure and epinephrine 
and between heart rate and norepinephrine and epi-
nephrine were also found. Plasma renin activity was not 
significantly correlated with arterial pressure, heart rate 
or rate-pressure product in either position. 
These results suggest that plasma epinephrine is a 
determinant of systolic pressure when postural reflexes 
are minimized and that epinephrine may participate in 
control of cardiac work load, as reflected by rate-pres-
sure product in the absence of exercise or definable stress. 
(J Am Coli CardioI1985;5:352-6) 
Methods 
Study subjects. The subjects for this study were 31 white 
or Hispanic men ranging in age from 18 to 55 years. who 
were selected for the protocol because their arterial pressures 
on outpatient examination spanned the normal to mildly 
elevated range. None of the subjects had taken antihyper-
tensive medication for at least 6 months before the study. 
Complete medical history and physical examinations were 
normal except for the presence of borderline diastolic arterial 
pressure (90 to 100 mm Hg) on several occasions in 13 of 
the 31 subjects. When appropriate, screening examinations 
for causes of secondary hypertension were performed; all 
were normal. No subject had hyperglycemia, hyperlipide-
mia, hypokalemia, elevation of serum urea nitrogen or cre-
atinine, proteinuria or electrocardiographic abnormalities other 
than increased voltage in the precordial leads. Half of these 
subjects engaged in regular recreational physical exercise 
such as tennis or jogging. In the 2 year follow-up period 
for these subjects since these studies were performed, some 
have been placed on antihypertensive drug therapy. No one 
in the group has had evidence of coronary heart disease, 
heart failure or any complication of hypertensive cardio-
vascular disease. All subjects were studied as outpatients 
and permitted to continue their usual diet. 
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Study protocol. On the day of the study, subjects were 
permitted a clear fluid breakfast. They had been requested 
not to smoke or drink caffeinated beverages from the pre-
vious evening at II :00 PM until arrival at the laboratory. 
On arrival, each subject was weighed and then placed in 
the supine position. The cuff on an Arteriosonde was placed 
on one arm, leads for an electrocardiogram and cardiac 
tachometer were taped in place on the chest and an in-
dwelling catheter was inserted into an antecubital or forearm 
vein on the side opposite to the pressure cuff. For I hour, 
arterial pressure and heart rate were measured at 2 minute 
intervals while the subject remained supine. A blood sample 
for plasma catecholamines and renin activity was then taken. 
The subject then stood upright for 10 minutes until a second 
blood sample was taken. For each subject, the blood pres-
sure and heart rate were averages of the last 10 determi-
nations in the supine position and of 5 determinations during 
standing. 
Measurements. Plasma catecholamine concentrations, 
norepinephrine and epinephrine were determined in dupli-
cate by radioenzymatic assay as previously described (4,5). 
The coefficient of variation for interassay agreement is 9% 
for norepinephrine and II % for epinephrine. Plasma renin 
activity was determined by radioimmunoassay of generated 
angiotensin I (6). Coefficient of variation is 5%. 
Statistical analysis. Data were processed for statistical 
analysis by the SAS system of the CUNY computer center 
employing the GLM program for regression analysis. In 
each phase of the study, the analysis employed considered 
systolic or diastolic pressure and heart rate or rate-pressure 
product (systolic pressure x heart rate) (7) as the dependent 
variables for correlation in a multiple linear regression model 
with plasma norepinephrine, plasma epinephrine and plasma 
renin activity or their logarithms as independent variables 
(for example, systolic pressure = f30 + f31 . plasma norepi-
nephrine + f32 . plasma epinephrine + f3, . plasma renin 
activity). The overall relation was considered significant for 
Table 1. Clinical Characteristics of Study Group (n 31 ) 
Mean ± SE Range 
Age (yr) 36 ± I IX to 55 
Height (m) 1.77 ± 0.01 1.67 to 1.87 
Weight (kg) 74.4 ± 1.3 60.1 to 89.3 
Body mass index (kg/m") 23.9 ± 0.4 19.9 to 28.9 
Supine 
Systolic pressure (mm Hg) 117 ± 2 9X to 147 
Diastolic pressure (mm Hg) 79 ± 2 64 to 100 
Heart rate (beats/min) 59 ± 2 35 to 84 
Standing 
Systolic pressure (mm Hg) 122 ± 2 103 to ISO 
Diastolic pressure (mm Hg) 89 ± 2* 61 to 114 
Heart rate (beats/min) 71 ± 2* 44 to 99 
*p < 0.0 I compared with supine value by paired I test. SE ~ standard 
error. 
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l.tF less than or equal to 0.0 I. Specific correlation coefficients 
(r) for individual relations between the dependent and in-
dependent variables were also calculated. 
Results 
Supine measurements. Descriptive characteristics of the 
31 men who participated in this study are given in Table I. 
Although six were mildly overweight (body mass index 25 
to 29), none was obese. The range of diastolic arterial pres-
sure in the supine position varied from normal to mild el-
evation (defined as 90 to 104 mm Hg). The low average 
supine heart rate may reflect the degree of physical fitness 
of this group in agreement with the frequent history of 
regular exercise. The distribution of supine systolic and 
diastolic pressures is shown in Figure I. 
Measurements on standing. As indicated in Table I, 
diastolic pressure and heart rate increased significantly dur-
ing standing. Measurements of plasma norepinephrine and 
epinephrine concentration in the two positions are shown in 
Figure 2. Standing significantly increased both plasma cate-
cholamines. In the supine position plasma renin activity was 
1.4 ± 0.2 ng/ml per h. A significant increase (+0.8 ± 
0.3 ng/ml per h, p < 0.02 by paired t test) occurred during 
standing. 
Correlations among blood pressure, heart rate, plasma 
catecholamines and renin activity. Table 2 presents the 
statistical analysis for relations among the dependent and 
independent variables that were analyzed. In the supine 
position, a highly significant relation was found between 
systolic pressure or rate-pressure product and independent 
Figure 1. Frequency histograms of systolic (a) and diastolic (b) 
pressures in 31 subjects in the supine position. The midpoint of 
each interval is given on the abscissa, the number (n) of subjects 
on the ordinate. 
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POSTURE AND CATECHOLAMINES 
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Figure 2. Mean plasma norepinephrine (NE) and epinephrine (E) 
concentrations in supine and standing positions. Results are ex-
pressed as mean ± standard error. Significant increases occurred 
in both plasma catecholamine concentrations on standing. 
variables, Highly significant individual correlations between 
systolic pressure or rate-pressure product and plasma epi-
nephrine were also found, For the log-transformed inde-
pendent variables, systolic pressure was significantly cor-
related (F = 8.18, P < 0.001) only with epinephrine (Fig. 
3). Neither diastolic pressure nor heart rate was significantly 
related to the three independent variables in the supine po-
sition by multiple regression analysis. A weakly significant 
correlation was evident between heart rate alone and plasma 
norepinephrine. 
Table 2 also displays the statistical relations for the stand-
ing position. Only rate-pressure product is significantly re-
lated to independent variables in the model employed. A 
highly significant correlation was found between rate-
Table 2. Statistical Analysis 
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SUPINE PLASMA EPINEPHRINE AND 
SYSTOLIC ARTERIAL PRESSURE 
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Figure 3. Relation between systolic arterial pressure and plasma 
epinephrine in 31 subjects in the supine position (r = 0.68, p = 
0.0001). 
pressure product and plasma epinephrine. Weakly signifi-
cant individual correlations were observed between systolic 
pressure and plasma epinephrine and between heart rate and 
plasma norepinephrine or epinephrine. 
Correlation with age and weight. In the supine posi-
tion, neither age nor weight was significantly correlated with 
either plasma catecholamine concentration or plasma renin 
activity. During standing, there was a significant positive 
correlation between age and plasma epinephrine (r = 0.45, 
p < 0.05), but not between age and norepinephrine or renin 
activity. Weight was not significantly correlated with stand-
ing plasma catecholamine concentration or renin activity. 
Correlation Coefficients (r) 
NE E PRA 
Supine 
Systolic pressure 6.96* 0.26 0.65* <0.1 
Diastolic pressure 0.41 0.31 0.15 <0.1 
Heart rate 2.30 0.22 0.44t <0.1 
Rate-pressure product 6.85* 0.29 0.65 <0.1 
Standing 
Systolic pressure 1.04 0.12 0.37t 0.20 
Diastolic pressure 0.30 0.22 <0.1 <0.1 
Heart rate 1.62 0.36t 0.42t <0.1 
Rate-pressure product 5.44* 0.36t 0.56* 0.16 
*p < 0.01; to.OI < p < 0.05. The F value is given for the entire statistical model (see Methods), whereas 
the r value is shown for individual correlations. E = plasma epinephrine; NE = plasma norepinephrine; PRA 
= plasma renin activity. 
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Discussion 
Plasma catecholamines and sympathoadrenal func-
tion. Plasma norepinephrine and epinephrine are measures 
of sympathoadrenal function. Various stimuli cause signif-
icant increases in plasma catecholamine concentration (8- 10). 
Increased sympathetic tone is necessary for the maintenance 
of arterial pressure in response to upright posture; in normal 
subjects standing causes a doubling of plasma norepineph-
rine. Patients with idiopathic orthostatic hypotension have 
no postural increase in the concentration of this catechol-
amine (8,11). 
Many previous studies have explored possible relations 
between sympathetic function, as reflected by plasma nor-
epinephrine, and essential hypertension. Although there is 
a slight trend toward elevation of plasma norepinephrine in 
hypertensive compared with control groups, when many 
studies are pooled interpretation is difficult because of vari-
ation in control groups and categorization of the hyperten-
sive subjects as to etiology of disease or cardiac status (12). 
Furthermore, plasma norepinephrine reflects spillover from 
that which is released from nerve endings and escapes neural 
re-uptake or local metabolism (13). Unless sympathetic 
function is activated by a potent stimulus, plasma norepi-
nephrine remains far below its apparent physiologic thresh-
old for effect as a circulating hormone (14). 
Plasma epinephrine in the normal and hypertensive 
subject. Circulating epinephrine reflects secretion from the 
adrenal medullae. Supine plasma epinephrine concentration 
is normally in a remarkably low range; the mean concen-
tration is about half the apparent physiologic threshold for 
effects on systolic pressure and heart rate as determined by 
infusion of exogenous epinephrine (15). Infusion studies 
may overestimate the threshold for endogenous epinephrine 
unless the preinfusion plasma level of the amine is far below 
threshold concentration (that is, such that adrenergic recep-
tors are unoccupied before infusion). It is then possible that 
plasma epinephrine concentration has some physiologic ef-
fect at levels found in the circulation in unstressed states. 
Previous publications (16,17) have reported elevations 
of plasma epinephrine concentration in patients with estab-
lished hypertension compared with normal subjects. High 
levels of plasma epinephrine concentration have also been 
found in "borderline hypertensives," but no correlation 
with arterial pressure has been described (18,19). More 
recently, it has been reported (20) that supine plasma epi-
nephrine concentration was significantly higher in a small 
number (n = 9) of subjects with "high normal" arterial 
pressure compared with subjects with a "low normal" pres-
sure drawn from a large healthy working population in West-
ern Australia. However, the only significant regression re-
lation was between systolic pressure and plasma epinephrine 
in the "low" group. Amann et aL (21) reported that in 
patients with essential hypertension, plasma epinephrine 
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concentration is positively correlated with alpha receptor-
mediated vasoconstriction in the forearm as revealed by 
blockade with intraarterial prazosin. In normotensive sub-
jects, the correlation is not observed. 
Results of this study. Our study evaluated well char-
acterized normal volunteers and patients referred for bor-
derline arterial pressure or uncomplicated mild hyperten-
sion. Although this group may be viewed as selected and 
not representing an unbiased sample of the population at 
large, it is free of factors that might alter plasma catechol-
amine concentration independent of changes in arterial pres-
sure, such as coronary heart disease or diabetes (22). 
Our results indicate that plasma epinephrine concentra-
tion is highly correlated with systolic arterial pressure in the 
supine position when reflexes mediating postural adjustment 
are less active. During both supine and upright posture, the 
heart rate x systolic pressure product correlated positively 
with plasma epinephrine but not norepinephrine. In contrast, 
diastolic pressure was not significantly correlated with plasma 
catecholamine concentration or renin activity as an inde-
pendent variable in either the supine or the standing position. 
Role of circulating epinephrine in control of blood 
pressure. These results do not establish the extent to which 
circulating epinephrine itself controls systolic arterial pres-
sure or rate-pressure product. It may be that plasma epi-
nephrine reflects global sympathoadrenal tone to a greater 
extent than does plasma norepinephrine, which spills into 
the circulation from the large number of sympathetic nerve 
terminals as well as the adrenal medullae. The specific role 
of circulating epinephrine need not be limited to direct ef-
fects on cardiac beta-receptors increasing heart rate and 
contractility or vascular beta2-receptors causing vasodila-
tion. Recent studies (23) suggested that circulating epi-
nephrine may be taken up and secreted by adrenergic neu-
rons as a "co-transmitter" or participate in presynaptic 
regulation of adrenergic neurosecretion. 
Implications. Systolic arterial pressure is a well defined 
and independent risk factor for future cardiovascular disease 
(24,25). In the past, elevation of systolic pressure has been 
viewed as secondary to structural alterations in large arter-
ies, that is, evidence of early atherosclerosis. Our results 
support the view that sympathoadrenal mechanisms may 
actively participate in determining systolic arterial pressure 
at rest and, as reflected by plasma epinephrine concentra-
tion, may control the work of the heart (that is, rate-pressure 
product) far more than was previously appreciated. Further 
studies are needed to characterize the determinants of plasma 
epinephrine in normal and hypertensive subjects and to es-
tablish the causal physiologic relations among circulating 
epinephrine, cardiovascular function and long-term cardio-
vascular risk. 
We thank Ellen Elting for technical expertise and Ruth Gonsky and Elaine 
Grohman for careful preparation of this manuscript. 
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